TY - JOUR
T1 - Utility of 3D Imaging in the Objective Evaluation of Glabellar Lines Following Botulinum Toxin Treatment
AU - Yan, Chenhui
AU - Huang, Chenyu
AU - Chen, Dian
AU - Hu, Xiaoming
AU - Ren, Jie
AU - Zhao, Yi
N1 - Publisher Copyright:
© 2026 by the authors.
PY - 2026/3
Y1 - 2026/3
N2 - Background/Objectives: Objective and reproducible evaluation of glabellar lines remains challenging, as current clinical assessments rely largely on subjective rating scales and two-dimensional photography, which lack depth information. This study aimed to assess the clinical utility of a laser-based three-dimensional (3D) imaging approach for objective quantitative evaluation of glabellar lines in adults undergoing botulinum toxin treatment. Methods: A laser-based 3D imaging system was used to quantitatively measure glabellar line morphology. System accuracy for area, perimeter, volume, and depth was evaluated using standardized physical models. In a prospective observational study, 31 adults with moderate-to-severe glabellar lines undergoing routine botulinum toxin treatment were assessed at baseline, day 7, and week 4. Quantitative 3D measurements were compared with clinician- and participant-reported severity scores, as well as patient satisfaction and Global Rating of Outcome (GRO) scores. Results: The 3D imaging measurements demonstrated high geometric measurement precision, with errors ≤2% for area, perimeter, and volume, and ≤0.5 mm for depth. Significant reductions in wrinkle depth were observed after treatment. Quantitative 3D measurements showed moderate correlations with clinician-reported scores (r = 0.53–0.54) and participant-reported scores (r = 0.59–0.66). Improvement rates derived from 3D measurements were positively correlated with patient satisfaction and GRO scores. Conclusions: Laser-based 3D imaging provides an objective and quantitative approach for evaluating glabellar lines and treatment response to botulinum toxin. This method may complement conventional clinical assessments and support further validation in larger clinical studies.
AB - Background/Objectives: Objective and reproducible evaluation of glabellar lines remains challenging, as current clinical assessments rely largely on subjective rating scales and two-dimensional photography, which lack depth information. This study aimed to assess the clinical utility of a laser-based three-dimensional (3D) imaging approach for objective quantitative evaluation of glabellar lines in adults undergoing botulinum toxin treatment. Methods: A laser-based 3D imaging system was used to quantitatively measure glabellar line morphology. System accuracy for area, perimeter, volume, and depth was evaluated using standardized physical models. In a prospective observational study, 31 adults with moderate-to-severe glabellar lines undergoing routine botulinum toxin treatment were assessed at baseline, day 7, and week 4. Quantitative 3D measurements were compared with clinician- and participant-reported severity scores, as well as patient satisfaction and Global Rating of Outcome (GRO) scores. Results: The 3D imaging measurements demonstrated high geometric measurement precision, with errors ≤2% for area, perimeter, and volume, and ≤0.5 mm for depth. Significant reductions in wrinkle depth were observed after treatment. Quantitative 3D measurements showed moderate correlations with clinician-reported scores (r = 0.53–0.54) and participant-reported scores (r = 0.59–0.66). Improvement rates derived from 3D measurements were positively correlated with patient satisfaction and GRO scores. Conclusions: Laser-based 3D imaging provides an objective and quantitative approach for evaluating glabellar lines and treatment response to botulinum toxin. This method may complement conventional clinical assessments and support further validation in larger clinical studies.
KW - glabellar lines
KW - objective assessment
KW - quantitative evaluation
KW - three-dimensional imaging
KW - wrinkle depth
UR - https://www.scopus.com/pages/publications/105032575096
U2 - 10.3390/diagnostics16050679
DO - 10.3390/diagnostics16050679
M3 - Article
AN - SCOPUS:105032575096
SN - 2075-4418
VL - 16
JO - Diagnostics
JF - Diagnostics
IS - 5
M1 - 679
ER -